Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer

NCT02453009 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

246

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Docetaxel
DRUG: Prednisone
DRUG: Enzalutamide

Sponsor

Santa Chiara Hospital